Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

C7 Antikörper (AA 233-453)

Der Kaninchen Polyklonal Anti-C7-Antikörper wurde für WB und ELISA validiert. Er ist geeignet, C7 in Proben von Human, Maus und Ratte zu detektieren.
Produktnummer ABIN5692807

Kurzübersicht für C7 Antikörper (AA 233-453) (ABIN5692807)

Target

Alle C7 Antikörper anzeigen
C7 (Complement Component C7 (C7))

Reaktivität

  • 35
  • 14
  • 4
  • 2
Human, Maus, Ratte

Wirt

  • 41
  • 7
  • 2
Kaninchen

Klonalität

  • 44
  • 5
Polyklonal

Konjugat

  • 31
  • 7
  • 6
  • 2
  • 2
  • 1
  • 1
Dieser C7 Antikörper ist unkonjugiert

Applikation

  • 43
  • 31
  • 18
  • 14
  • 13
  • 10
  • 5
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
Western Blotting (WB), ELISA
  • Bindungsspezifität

    • 8
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 233-453

    Verwendungszweck

    Anti-Complement C7 Antibody Picoband®

    Marke

    Picoband™

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins.

    Produktmerkmale

    Rabbit IgG polyclonal antibody for Complement C7 detection. Tested with WB, Direct ELISA in Human,Mouse,Rat.

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    E. coli-derived human Complement C7 recombinant protein (Position: R233-D453).

    Isotyp

    IgG
  • Applikationshinweise

    Western blot, 0.1-0.5 μg/mL
    ELISA, 0.1-0.5 μg/mL
    1. Barroso, S., Rieubland, C., Alvarez, A. J., Lopez-Trascasa, M., Bart, P.-A., Nunez-Roldan, A., Sanchez, B. Molecular defects of the C7 gene in two patients with complement C7deficiency. Immunology 118: 257-260, 2006. 2. Coto, E., Martinez-Naves, E., Dominguez, O., DiScipio, R. G., Urra, J. M., Lopez-Larrea, C.DNA polymorphism and linkage relationship of the human complement component C6,C7, and C9 genes. Immunogenetics 33: 184-187, 1991.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Konzentration

    500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg NaN3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.
  • Target

    C7 (Complement Component C7 (C7))

    Andere Bezeichnung

    C7

    Hintergrund

    Synonyms: Complement component C7, C7

    Tissue Specificity: Widely expressed.

    Background: This gene encodes a serum glycoprotein that forms a membrane attack complex together with complement components C5b, C6, C8, and C9 as part of the terminal complement pathway of the innate immune system. The protein encoded by this gene contains a cholesterol-dependent cytolysin/membrane attack complex/perforin-like (CDC/MACPF) domain and belongs to a large family of structurally related molecules that form pores involved in host immunity and bacterial pathogenesis. This protein initiates membrane attack complex formation by binding the C5b-C6 subcomplex and inserts into the phospholipid bilayer, serving as a membrane anchor. Mutations in this gene are associated with a rare disorder called C7 deficiency.

    Molekulargewicht

    93 kDa

    Gen-ID

    730

    UniProt

    P10643

    Pathways

    Komplementsystem
Sie sind hier:
Chat with us!